跳到正文
原文
Endpoints News 生物医药· Nicole DeFeudis·· 26 天前AI 评分23

ESMO26:默克与Moderna的个性化癌症疫苗数据为“科学的胜利”,工作正式开始

#ESMO26: Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins

AI 导读

在ESMO26会议上,默克与Moderna发布的个性化癌症疫苗数据被评价为“科学的胜利”,相关工作正式开启。临床医生对该数据表现出浓厚兴趣,但具体研究结果和后续进展因原文订阅限制未完全披露。

正文

MADRID — In a tes­ta­ment to clin­i­cians’ in­ter­est in Mer­ck and Mod­er­na’s per­son­al­ized can­cer vac­cine da­ta at this year’s Eu­ro­pean So­ci­ety for Med­ical On­col­o­gy con­fer­ence, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news